| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/15/2002 | US20020110546 Implanting cells of an immortalized human neuro-derived fetal cell line into the host for therapy |
| 08/15/2002 | CA2796884A1 Improved controlled release oral dosage form |
| 08/15/2002 | CA2685214A1 Improved controlled release oral dosage form |
| 08/15/2002 | CA2442343A1 Method of treating neurological disorders using acetone derivatives |
| 08/15/2002 | CA2437717A1 G-protein coupled receptors |
| 08/15/2002 | CA2437648A1 Multipotent o-2a progenitors from the neurohypophysis |
| 08/15/2002 | CA2437571A1 Receptors and membrane-associated proteins |
| 08/15/2002 | CA2437497A1 Lipid-associated molecules |
| 08/15/2002 | CA2437453A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 08/15/2002 | CA2437405A1 Potassium channel openers |
| 08/15/2002 | CA2437400A1 Aminal diones as potassium channel openers |
| 08/15/2002 | CA2437263A1 Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity |
| 08/15/2002 | CA2437260A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 08/15/2002 | CA2437248A1 Jnk inhibitor |
| 08/15/2002 | CA2437215A1 Dihydropyrazolopyridine compounds and pharmaceutical use thereof |
| 08/15/2002 | CA2437185A1 Timm8b-related protein |
| 08/15/2002 | CA2437085A1 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 08/15/2002 | CA2436741A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents |
| 08/15/2002 | CA2436738A1 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose |
| 08/15/2002 | CA2436735A1 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof |
| 08/15/2002 | CA2436470A1 Intracellular signaling molecules |
| 08/15/2002 | CA2435844A1 Method and composition for rejuvinating cells, tissues, organs, hair and nails |
| 08/15/2002 | CA2435620A1 Enteric nervous system derived stem and progenitor cells and uses thereof |
| 08/15/2002 | CA2434944A1 Secreted proteins |
| 08/15/2002 | CA2434302A1 Therapeutic and diagnostic compounds, compositions, and methods |
| 08/15/2002 | CA2433439A1 Proteins and nucleic acids encoding same |
| 08/15/2002 | CA2432188A1 Thiazole derivatives for treating ppar related disorders |
| 08/14/2002 | EP1231263A1 Multipotent O-2A progenitors from the neurohypophysis |
| 08/14/2002 | EP1231213A1 Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields |
| 08/14/2002 | EP1231212A1 Pharmaceutical compositions for the treatment of disorders of the CNS and other disorders |
| 08/14/2002 | EP1230921A1 Combination treatment for depression |
| 08/14/2002 | EP1230551A2 Methods to identify compounds that modulate neuronal activity |
| 08/14/2002 | EP1230367A1 19 human secreted proteins |
| 08/14/2002 | EP1230361A2 G protein-coupled receptors expressed in human brain |
| 08/14/2002 | EP1230360A2 15 human secreted proteins |
| 08/14/2002 | EP1230356A2 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 08/14/2002 | EP1230342A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 08/14/2002 | EP1230271A1 Hedgehog fusion proteins and uses |
| 08/14/2002 | EP1230263A1 A novel molecule |
| 08/14/2002 | EP1230259A1 S-allylmercaptoglutathione and uses thereof |
| 08/14/2002 | EP1230255A1 25 human secreted proteins |
| 08/14/2002 | EP1230244A2 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 08/14/2002 | EP1230243A1 Poycyloalkylpurines as adenosine receptor antagonists |
| 08/14/2002 | EP1230242A1 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 08/14/2002 | EP1230241A2 Adenosine receptor antagonists and methods of making and using the same |
| 08/14/2002 | EP1230236A1 Compound with growth hormone releasing properties |
| 08/14/2002 | EP1230227A1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 08/14/2002 | EP1230222A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 08/14/2002 | EP1230220A1 Beta-aminoacid compounds useful for inhibiting beta-amyloid peptide release and/or its synthesis |
| 08/14/2002 | EP1230218A1 Positive modulators of nicotinic receptor agonists |
| 08/14/2002 | EP1230217A1 Positive modulators of nicotinic receptor agonists |
| 08/14/2002 | EP1230216A1 Positive modulators of nicotinic receptor agonists |
| 08/14/2002 | EP1230215A1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 08/14/2002 | EP1230214A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 08/14/2002 | EP1230210A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders |
| 08/14/2002 | EP1230205A1 Method for producing compounds of the valproinic acid |
| 08/14/2002 | EP1229934A2 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 08/14/2002 | EP1229919A2 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate |
| 08/14/2002 | EP1229905A2 Transdermal drug delivery devices comprising (r)-(z)-1- azabicyclo[2.2.1]heptan-3-one, o-[3(3-methoxyphenyl)-2-propynyl]oxime |
| 08/14/2002 | EP1189922A4 Steroid derivatives |
| 08/14/2002 | EP1087961B1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same |
| 08/14/2002 | EP1071455A4 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 08/14/2002 | EP0956281B1 Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene and processes for preparing said compound |
| 08/14/2002 | EP0937076B1 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 08/14/2002 | EP0907364B1 Sustained release pharmaceutical compositions comprising a dibenzothiazepine derivative |
| 08/14/2002 | EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/14/2002 | EP0759920B1 Derivatives of quinuclidine n-oxide as muscarinic receptor ligands |
| 08/14/2002 | DE10105989A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 08/14/2002 | DE10105041A1 Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases |
| 08/14/2002 | DE10105040A1 Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems Tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 08/14/2002 | DE10105038A1 Tripeptide und Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 08/14/2002 | DE10103506A1 Pharmazeutische Zusammensetzung zur Behandlung von Multiple Sklerose A pharmaceutical composition for the treatment of Multiple Sclerosis |
| 08/14/2002 | DE10102722A1 Verfahren und Testsystem zum Auffinden von Nervenzell-schützenden Substanzen Method and test system for the detection of nerve cell-protective substances |
| 08/14/2002 | CN1364166A Polymorphic salt as medicine for migraine |
| 08/14/2002 | CN1364157A N-(indolcarbonyl) piperazin derivatives |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/14/2002 | CN1364153A Substituted phenoxyacetic acids |
| 08/14/2002 | CN1364088A IL6RIL6 chinese for treatment of neurodegenerative diseases |
| 08/14/2002 | CN1364087A Methods of treatment and drug screening methods |
| 08/14/2002 | CN1364079A Transnasal anticonvulsive compositions and modulated process |
| 08/14/2002 | CN1363339A Nano medicine 'Compound Kendir' and its preparing process |
| 08/14/2002 | CN1363308A Nano medicine 'Jisheng Shenqi' and its preparing process |
| 08/14/2002 | CN1363283A Beetoxin injection and its preparing process |
| 08/14/2002 | CN1363275A Application of paralytic PSP toxin in preparing antalgesic medicine |
| 08/13/2002 | US6433225 Process for the preparation of fluvoxazmine maleate |
| 08/13/2002 | US6433182 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
| 08/13/2002 | US6433179 Process for producing paroxetine |
| 08/13/2002 | US6433178 3-alkyl-3-phenyl-piperidines |
| 08/13/2002 | US6433175 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 08/13/2002 | US6433171 Dipeptide derivatives |
| 08/13/2002 | US6433165 Chemokine receptor antagonists and methods of use therefor |
| 08/13/2002 | US6433149 Compounds and methods for inhibiting cancer metastasis |
| 08/13/2002 | US6433019 Administering a nitric oxide donor to treat neurodegenerative disorders |
| 08/13/2002 | US6433014 1-aminocyclopentane-1-carboxylic acid derivative glutamatergic receptor agonists and antagonists; central nervous system disorders; alzheimer*s and parkinson*s disease treatment |
| 08/13/2002 | US6433009 Treatment of autoimmune, cardiovascular, nervous system, gastrointestinal, respiratory system, and viral disorders; antidiabetic, antiarthritic, antiinflammatory and antidepressant agents |
| 08/13/2002 | US6433005 Selective cox ii inhibitor |
| 08/13/2002 | US6433004 Substituted β,γ-anellated lactones |
| 08/13/2002 | US6432996 Pharmaceutical composition |
| 08/13/2002 | US6432989 Use of CRF antagonists to treat circadian rhythm disorders |
| 08/13/2002 | US6432985 4-benzyl-1-(2-(p-hydroxyphenoxy)ethyl)piperidine-3,4-diol; preparation from 1-(2-haloethoxy)-4-benzyloxybenzene and 4-benzylpiperidine-3,4-diol |